FDA Inspection 1160001 — Nemaura Pharma Limited
The FDA completed an inspection of Nemaura Pharma Limited on Dec 10, 2021 in Loughborough. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 10, 2021
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Loughborough (United Kingdom)
Additional Details
Sponsor, Contract Research Organization